Post

New research · Ophthalmology
Investigative ophthalmology & visual science · 2d
Cohort studyInvestigative ophthalmology & visual science · 2026

Lens Opacity in ABCA4-Associated Stargardt Disease Patients in the ProgStar Study.

Folahan Ibukun, Bai Xi Jasmine Chan, Jehanzeb Khan … Xiangrong Kong
Read paper
OphthalmologyCohort study

Older age strongly linked to lens opacity in Stargardt disease patients

Lens Opacity in ABCA4-Associated Stargardt Disease Patients in the ProgStar Study.

Folahan Ibukun … Xiangrong Kong
Investigative ophthalmology & visual science · 2026
Purpose

The purpose of this study was to estimate lens opacity (lens opacity) and associated risk factors in patients with ABCA4 associated Stargardt disease (STGD1).

Methods

With molecularly confirmed STGD1 aged ≥6 years from the United States and Europe were enrolled and followed for 2 years.

n = 354 eyes
Results

each decade older meant much higher odds of cloudy lens

adjOR 4.60 (95% CI 2.60 to 7.90)
null 0
2.60
7.90
CI excludes the null - significant
More results

Of the 259 participants, 54% were women, 86% were Caucasian, and the median age of STGD1 symptom onset was 19 years.

At baseline, median age = 31 (interquartile range [IQR] = 21-44, range = 6-68) years; lens opacity prevalence = 14.3% (69/483) of study eyes.

More results

Among the 354 eyes without lens opacity at baseline, 2-year incidence was 5.6%.

Older age was associated with incidence: adjOR for every decade older = 4.1 (95% CI = 1.8-9.1).

“
Conclusion · 1 of 2

Lens opacity prevalence in ProgStar is higher than in age-matched general population. Age and age of symptom onset were risk factors of lens opacity, suggesting both biological and accelerated aging due to retinal degeneration in STGD1.

Conclusion · 2 of 2

Trials of STGD1 should closely monitor safety in the anterior segment and consider excluding patients expecting cataract surgery soon.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving